Immunosuppressants Market to be driven by Rise in the Number of Organ Transplants and Increase in the Prevalence of Autoimmune Disorders
An immunosuppressant stops the immune system from damaging healthy tissues and cells by slowing down or ceasing the response of the immune system that mistakenly attacks the healthy tissues and cells. They are usually prescribed to people with bone marrow or stem cell transplants and organ transplants to prevent transplanted tissues and organs. Immunosuppressants are also used to treat autoimmune disorders.
Global Immunosuppressants Market: Growth Factors
The global immunosuppressants market is growing at a speedy rate. Rise in focus on the development of monoclonal antibodies, growing demand for generic drugs, and increase in the prevalence of autoimmune disorders such as rheumatoid arthritis, lupus, & psoriasis are some of the essential factors that are spurring the growth of the global market. Further, the rise in the number of organ transplants is the key factor that is boosting the growth of the market. In 2018, the predicted number of organ transplants was more than 146,000, and nearly two-third of which were kidney transplants. In 2020, more than 39,000 organ transplants were performed in the US alone and as of Feb 2021, it is estimated that over 107,000 numbers of children, women, and men are on the national transplant waiting list.
In addition to this, there is a surge in the number of chronic kidney diseases leading to the rise in the number of kidney transplants and growing cases of acute leukemia, refractory anemia, & osteopetrosis necessitating stem cell transplants. Such a huge burden of organ transplants has led to the surge in the demand for immunosuppressants thereby fostering the growth of the global immunosuppressants market. In addition to this, rise in the number of clinical trials, growing mergers & acquisitions for the expansion of pipeline drugs, and rapid expansion of CDMOs & CROs supporting the discovery & development of the drugs are also some of the crucial factors that are contributing to the overall growth of the market.
Get Sample of this Research Report for more Insights - https://www.zionmarketresearch.com/sample/immunosuppressants-market
Moreover, factors such as an increase in healthcare expenditure and the development of healthcare infrastructure in developing countries are also the aspects that are propelling the growth of the global market. Furthermore, advancements in technologies to understand the molecular processes will enhance the discovery of innovative immunosuppressant drugs and offer several opportunities for the growth of the global immunosuppressants market over the forecast period. However, strict regulations regarding quality, clinical, and non-clinical aspects for the approval of the immunosuppressant drugs may hinder the growth of the global immunosuppressants market.
The transplant surgeries, organ transplants, and related surgeries were suspended or postponed during the Covid-19 pandemic due to strict measures such as complete lockdown and restriction on movement taken to avert the spread of the virus. The decision of temporary suspension of the organ transplant program was taken as the people undergoing transplant are at a high risk of contracting the infection. Thus, all these factors coupled with the shift of healthcare workers towards the treatment of Covid-19 patients have impacted the growth of the global immunosuppressants market amid the Covid-19 pandemic.
Global Immunosuppressants Market: Segmentation
The global immunosuppressants market is bifurcated based on indication, drug class, distribution channel, and region. Based on indication, the global immunosuppressants market is categorized into non-autoimmune inflammatory diseases, autoimmune disorders, and organ transplantation. The drug class segment consists of anti-proliferative agents, mTOR inhibitors, calcineurin inhibitors, monoclonal antibodies (mAbs), corticosteroids, and others. Online pharmacies, retail pharmacies, and hospital pharmacies are the distribution channels in the global market.
Global Immunosuppressants Market: Regional Analysis
Based on the region, North America is projected to lead the global immunosuppressants market during the forecast period. Factors such as growing incidences of organ transplants, heavy investment in immunosuppressant drug discovery, and favorable reimbursement policies are boosting the growth of the market in this region. Asia Pacific is expected to register the fastest growth owing to an increase in healthcare expenditure, emerging market players attracted towards India & China for business expansion, and government initiatives to undergo a kidney transplant in low & middle-income countries.
Global Immunosuppressants Market: Competitive Players
Astellas Pharma, Inc, Sanofi S.A, Pfizer Inc., Novartis AG, Mylan Laboratories Inc., Johnson & Johnson, Intas Pharmaceuticals Ltd., GlaxoSmithKline Plc., F. Hoffmann La Roche Ltd., and Bristol Myers Squibb among others are some of the major players that are operating in the global immunosuppressants market.
Request for Customize this Report - https://www.zionmarketresearch.com/custom/6276
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us –
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651